This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07668/identifier/pdb/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07668/identifier/pubchem-compound/
n7http://bio2rdf.org/drugbank:
n12http://linked.opendata.cz/resource/drugbank/drug/DB07668/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB07668/identifier/drugbank/
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB07668/identifier/chemspider/

Statements

Subject Item
n2:DB07668
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB07668 n7:DB07668
dcterms:title
3-(4-DIETHYLAMINO-2-HYDROXY-PHENYL)-2-METHYL-PROPIONIC ACID
adms:identifier
n10:4450319 n11:DB07668 n12:99444139 n13:DMC n14:5288082
n5:IUPAC-Name
n6:271B5AE7-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5AED-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5AEC-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5AE9-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5AEA-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5AEB-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5AE5-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5AE6-363D-11E5-9242-09173F13E4C5 n6:271B5AE3-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5AE4-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5AF3-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5AF4-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5AEE-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5AEF-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5AF1-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5AF0-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5AF2-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5AF9-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5AFB-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5AFC-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5AF8-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5AF7-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5AFA-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5AE8-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5AF5-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5AF6-363D-11E5-9242-09173F13E4C5